[Infliximab: remicade].
Bachelez
H
H
Service de Dermatologie 1 et Université Paris 7, AP-HP, Hôpital Saint-Louis, 1, avenue Claude Vellefaux, 75010 Paris. herve.bachelez@sls.aphp.fr
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D012871:Skin Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab